Tom Price’s Wife Gives Medical Industry Donors a Way to Influence National Policy

Betty Price, a Georgia state lawmaker, has received contributions from the industry since her husband’s nomination for health secretary was announced.

Ron Sachs/ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Tom Price, President Donald Trump’s pick for health secretary, has faced criticism in recent weeks that he’s too closely tied to the health industry he may soon be charged with regulating. Democrats have focused on accusations that Price personally profited by buying stock in various medical companies before writing legislation that would boost the standing of those same companies. Price has denied all wrongdoing, and promised that if confirmed, he’d sell off any financial stake in medical and pharmaceutical companies.

But the industry still has another way to funnel money in Price’s direction: by donating to his wife’s political campaigns.

Betty Price has represented the 48th district in the Georgia state House since winning a special election in July 2015. In November, she became a member of the Republican deputy whip team in the House. An anesthesiologist prior to the launch of her political career, Betty has leaned on the health industry, both in Georgia and nationally, for campaign donations. And the medical industry has maintained its financial support for her since her husband was picked by Trump—despite the fact that Betty Price won’t face reelection for another two years.

The ethics agreement Price had to file as a part of his nomination as health secretary hinted at the idea that his wife’s political position might clash with his role as head of the Department of Health and Human Services. In the agreement, Price promised to recuse himself from “any particular matter involving specific parties in which I know the state of Georgia is a party or represents a party.” That’s going to be a tricky proposition for Price to carry out at HHS: The Centers for Disease Control and Prevention are based in Atlanta and under the purview of the HHS secretary.

Price makes no mention of his wife’s political funding in the ethics agreement. Georgia is one of 28 states that allow corporations to donate funds directly to political candidates. Campaigns for the Georgia legislature can accept up to $2,500 per election cycle from a corporate entity. Betty Price ran unopposed for reelection in both the primary and general election in 2016, garnering 100 percent of the 17,886 votes in her district. She received donations from local groups like Georgia Medical PAC—to be expected given her own background in medicine and her seat on the state House’s health and human services committee.

National health care groups also took an interest in her uncontested state legislative race, donating at least $4,500 to her campaign, per public campaign finance reports. New Jersey-based Johnson & Johnson donated $500; Minnesota-based United Health chipped in another $500. She received more than just direct contributions from health care companies: The employee PAC for Illinois-based Abbott Laboratories contributed $1,000.

The donations have not slowed since she won reelection in November. In the month after Trump announced Tom Price as his HHS pick, Betty Price’s campaign fund reported receiving at least $2,250 in donations from national and state medical groups. On her end-of-the-year campaign finance report, she reported having received $500 from drug-manufacturing giant Pfizer (headquartered in New York) the day after Tom Price’s nomination was announced. (A Pfizer spokeswoman says that the donation was actually made last August, and the company reported it on its own campaign contribution disclosure as having been made in August.)* San Francisco biotechnology company Genentech contributed $500 later in December.

These donations are not unique to Betty Price. Pfizer also donated to 22 other Georgia state legislators after the November election, and Genentech donated to five others. But these companies cannot donate directly to Price’s congressional efforts, nor will they be able to donate to him as HHS secretary, so his wife’s campaign could give them a path to curry favor with the man who will oversee their industry.

Betty and Tom Price’s offices did not respond to requests for comment on whether her campaign would rethink corporate donations from the medical industry if Price is confirmed to lead HHS.

As a congressman from Georgia, Tom Price has been a favorite recipient of donations from medical professionals at the national level—though thanks to stricter federal campaign finance laws, Price couldn’t collect direct corporate donations. According to OpenSecrets, over the course of Price’s career in Congress since 2006, health professionals have been by far his largest financial benefactor, donating more than $3.5 million. The second-largest group is insurance industry employees, with more than $800,000; in fourth place are people working in pharmaceuticals/health products, who have given more than $570,000. 

As health secretary, Price would oversee Food and Drug Administration approval of new drugs and decide which treatments insurers are required to cover. The companies that donate to Betty Price will have a direct stake in these decisions. And with Betty Price still able to collect campaign contributions, they also have a way to try to influence them.

This story has been updated to include Pfizer’s information on the timing of its donation to Betty Price.

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate